Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 1,742 shares at $155.46 ($271K) on 2025-08-14, disclosed to the SEC on 2025-08-15.
Scheduled sale ($271k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.42 | 8 | $1K | 0.5% |
| 2 | $155.46 | 867 | $135K | 49.8% |
| 3 | $155.46 | 867 | $135K | 49.8% |
| Total | $155.46 avg | 1,742 | $271K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |